Thrombocytopenic purpura
MONDO:0043768Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.
Also known as: thrombocytopenic purpura, purpura, thrombopenic, purpuras, thrombocytopenic, purpuras, thrombopenic, thrombocytopenic purpuras, thrombopenic purpura, thrombopenic purpuras
128 clinical trials for this condition and its sub-types, 8 tagged with Thrombocytopenic purpura itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Thrombocytopenic purpura
-
Autoimmune thrombocytopenic purpura 95 trials
-
Thrombotic thrombocytopenic purpura 15 trials · 20 incl. sub-types
2 sub-types
-
Tailored drug regimen shows promise for rare blood disorder
Disease control Stopped earlyThis study tested whether giving the drug caplacizumab based on regular blood tests (ADAMTS13 activity) could improve outcomes for adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare condition causing dangerous blood clots. The trial enrolled 58 adults and mon…
Phase 2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Experimental drug iptacopan tested for rare blood disorders
Disease control Stopped earlyThis study tested an experimental drug called iptacopan in people with two rare blood disorders: immune thrombocytopenia (ITP) and cold agglutinin disease (CAD). The goal was to see if the drug could improve platelet counts in ITP or hemoglobin levels in CAD. The trial was termin…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC